The Checkup by Singlecare
APRIL 10, 2025
Strattera (atomoxetine) is a brand name, non-stimulant drug approved by the U.S. Food and Drug Administration (FDA) to treat attention deficit hyperactivity disorder (ADHD). Its also prescribed off-label for other medical conditions, such as treating a specific type of low blood pressure called neurogenic orthostatic hypotension and reducing symptoms of major depressive disorder in people who also have ADHD.
Hospital Pharmacy Europe
APRIL 10, 2025
Non-adherence can negatively impact medication treatment strategies, particularly among oncology patients, driving up treatment costs while potentially worsening clinical outcomes. Although oral oncolytics offer convenience, they arguably require greater patient engagement in remembering to take their treatment, often resulting in lower adherence compared to infused therapies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
APRIL 10, 2025
Mark Ratain’s First Opinion piece of Feb. 4, 2025 , implies that the oncologists in NCI’s Investigational Drug Branch (IDB) colluded with the drug company Exilixis to sponsor two Phase 3 studies of its drug cabozantanib. He claims these studies showed minimal benefit, yet the results were used to inflate the value of Exilixis stock. Ratain concludes by recommending that IDB be abolished.
Hospital Pharmacy Europe
APRIL 10, 2025
A tool to streamline hospital outpatient clinics for geriatric oncology patients has been developed by a clinical pharmacist and clinical nurse specialist at the Royal Marsden NHS Foundation Trust. The eArly identifiCation advanCed gEriatric aSsesSment (ACCESS) tool facilitates integrated care by remotely assessing medications, nutrition, social support, mood, and functional status, enhancing clinical efficiency and patient outcomes.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
European Pharmaceutical Review
APRIL 10, 2025
There is worldwide concern around the use of PFAS. In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. This poses a significant challenge for pharmaceutical manufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.
STAT
APRIL 10, 2025
NEW YORK — A top Centers for Disease Control and Prevention official told staff this week to start planning for the agency’s splintering. Several parts of CDC — mostly those devoted to health threats that aren’t infectious — are being spun off into the soon-to-be-created Administration for a Healthy America, the agency official told senior leaders in calls and meetings.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
APRIL 10, 2025
A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences should issue compulsory licenses if the company fails to modify an existing licensing program with half a dozen generic makers. In an essay in Clinical Infectious Diseases , they complained Gilead pursued voluntary licenses that are too restrictive, which will delay or deny access to its drug.
Pharmafile
APRIL 10, 2025
Dosium Touchdose has gone live at West Middlesex University Hospital, UK, a clinical decision support technology proven to significantly reduce prescribing errors. This follows go-live at both Chelsea and Westminster Hospital last month, and St Marys Hospital last summer, marking the final stage of rollout across the entire West London Childrens Healthcare (WLCH) partnership.
STAT
APRIL 10, 2025
Mayo Clinic has hired Micky Tripathi, a former top health technology official under President Biden, to be its chief AI implementation officer, a role that involves overseeing the technology’s development and adoption within the sprawling health system. Tripathi most recently was the assistant secretary for technology policy and the national coordinator for health information technology.
Pharmafile
APRIL 10, 2025
AAX Biotech has appointed Ionut Gabriel Dumitru (pictured left) as senior scientist and Kushal Sejwal (pictured right) as business developer, contributing to its strategy to develop its research and business. The company experiences growing interest in its Seqitope and Opti-mAb technologies, platforms pioneering its mission to develop innovative antibody therapeutics.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
APRIL 10, 2025
The $6.3 trillion wellness industry thrives on distrust of science, glorifying “natural” alternatives, and fear-based marketing. The result? Pseudoscience that’s not just harming human health. It’s killing animals, too, specifically via H5N1 bird flu. Holistic pet health influencers, organic farmers, and alternative medicine advocates embrace behaviors that increase the risk of viral transmission, paving the way for a potential human pandemic.
European Pharmaceutical Review
APRIL 10, 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) and the University of Liverpool have issued their first analysis of the clinical trial landscape in the UK.The report, published in the British Journal of Clinical Pharmacology demonstrated that currently, UK clinical trials exhibit strong innovation, as well as a concentration of research in certain disease areas, and opportunities for increased representation of certain patient groups.
STAT
APRIL 10, 2025
Facing a growing outbreak of measles that could test his leadership, health secretary Robert F. Kennedy Jr. this week is sowing doubt about the safety and efficacy of some vaccines — beyond the measles shot — and arguing the government shouldn’t mandate their use. He also raised questions about what killed an 8-year-old girl whose death was attributed to measles by health officials, his latest remarks that downplay the threat of the virus.
The FDA Law Blog
APRIL 10, 2025
By Sarah Wicks & Anne K. Walsh The recent and drastic Reduction In Force (RIF) at the U. S. Food and Drug Administration (FDA) is already having ripple effects not just internally, but across the broader regulatory and life sciences communities and the public at large. While much of the focus has been on how these cuts may impact application review timelines and industry engagement, see earlier post about the effect on generic drugs, another quieter consequence is emerging a significant sl
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
APRIL 10, 2025
WASHINGTON — House Republicans’ struggles to pass a tax cut plan could be good news for the Medicaid program. On Thursday, House GOP lawmakers voted 216 to 214 to pass a budget blueprint that sets the stage for a bill later in the year on major tax cuts. The vote on the budget resolution was supposed to be the easy part—instead, House Speaker Mike Johnson had to delay the vote by a day after facing resistance from some far-right lawmakers.
Pharma Marketing Network
APRIL 10, 2025
What if the next patient who needs your medication is already searching onlineand youre not there? In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact. Gone are the days when print ads and in-person detailing alone could carry a brand.
Drug Topics
APRIL 10, 2025
A conversation with Douglas Hoey, CEO of the National Community Pharmacists Association, at the American Associated Pharmacies 2025 Annual Conference.
PhRMA
APRIL 10, 2025
These days, the same big health care conglomerate could own your PBM, insurer, pharmacy and even your doctor’s office. Middlemen now control what medicines you can get, what you pay at the pharmacy counter, what pharmacy you can you use and what hoops you must jump through to get the medicine your doctor prescribed.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
APRIL 10, 2025
Ashley Keller, CPhT, hosted a session at the Total Pharmacy Solutions Summit Spring 2025 exploring the services and strategies community pharmacies can employ to make their businesses thrive.
Pharmacy Times
APRIL 10, 2025
Data show that the system is also the most accurate continuous glucose monitor (CGM).
Drug Topics
APRIL 10, 2025
Using a cost-utility analysis, researchers addressed the cost-effectiveness of pneumococcal vaccine strategies for adults over the age of 64.
Fierce Healthcare
APRIL 10, 2025
More than two dozen healthcare associations are worried healthcare is on the wrong trajectory, as the aftermath of the reductions in force at HHS become clearer.
Drug Topics
APRIL 10, 2025
Hypertension and obstructive sleep apnea are considered independent risk factors for cardiovascular diseases as well as diabetes.
pharmaphorum
APRIL 10, 2025
HHS has said it plans to appeal a permanent injunction on big cuts to indirect funding for medical research awarded by the NIH.
Drug Topics
APRIL 10, 2025
Investigators find 5 distinct obesity trajectories that influenced brain morphology, function, and cognition.
pharmaphorum
APRIL 10, 2025
The first targeted drug for a common form of bladder cancer that can be taken at home.
Drug Topics
APRIL 10, 2025
Pharmacists have positive impacts on health outcomes for diabetes and patients using CGM devices, including reductions in A1c.
Pharmacy Times
APRIL 10, 2025
The approval is for those with metastatic disease or in whom surgical resection is likely to result in severe morbidity, have no satisfactory alternative treatments, or have progressed following treatment.
Drug Topics
APRIL 10, 2025
Throughout her research, Jenny Markell, BA, has uncovered some alarming trends within prescription drug advertising in the US.
Fierce Healthcare
APRIL 10, 2025
Recent executive actions aim to slash regulations the administration considers unlawful or anticompetitive. Under one order giving broad discretion to agencies, healthcare could start seeing the impacts as soon as April 19.
Drug Topics
APRIL 10, 2025
Jenna Anderson, CEO of KiHealth Inc, and Amanda Wiley, marketing manager of HealthSource Marketing, discuss the evolving role of pharmacies in at-home testing.
Pharmacy Times
APRIL 10, 2025
Many other issues on the new administrations plate are taking priority.
Drug Topics
APRIL 10, 2025
Female pharmacists make up approximately 62% of the pharmacy workforce. They want, and in many cases demand, a good work-life balance.
Expert insights. Personalized for you.
Let's personalize your content